KR870008910A - 돼지 이질의 예방 및 치료제 - Google Patents

돼지 이질의 예방 및 치료제 Download PDF

Info

Publication number
KR870008910A
KR870008910A KR870001938A KR870001938A KR870008910A KR 870008910 A KR870008910 A KR 870008910A KR 870001938 A KR870001938 A KR 870001938A KR 870001938 A KR870001938 A KR 870001938A KR 870008910 A KR870008910 A KR 870008910A
Authority
KR
South Korea
Prior art keywords
salts
swine dysentery
coch3
prevention
treatment
Prior art date
Application number
KR870001938A
Other languages
English (en)
Inventor
하시모토 쇼오지
야마시타 마찌오
우메하라 카즈요시
구누기타 기요히코
고하사카 마사노부
Original Assignee
후지사와 도모키찌로오
후지사와 야꾸힌 고오교오 가부시기가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 후지사와 도모키찌로오, 후지사와 야꾸힌 고오교오 가부시기가이샤 filed Critical 후지사와 도모키찌로오
Publication of KR870008910A publication Critical patent/KR870008910A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

내용없음

Description

돼지 이질의 예방 및 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 WS-1627A의1H NMR 흡수 스펙트럼이며,
제2도는 WS-1627C의1H NMR 흡수 스펙트럼이다.

Claims (4)

  1. 유효성분으로서 WS-1627A, WS-1627B, WS-1627C 및 WS-1627D에서 선택된 하나 또는 그 이상의 화합물 또는 그 염으로 구성되는 것을 특징으로 하는 돼지 이질의 예방 및 치료조성물.
  2. 돼지 이질에 접하거나 전염된 돼지에 WS-1627A, WS-1627B, WS-1627C 및 WS-1627D에서 선택된 하나 또는 그 이상의 화합물 또는 그 염의 유효량을 투여하는 것으로 구성되는 것을 특징으로 하는 치료 또는 예방하는 방법.
  3. 스트텝토마이세스 노보티토엔시스 아종 아마미엔시스에 속하는 WS-1627A, WS-1627B, WS-1627C 및 WS-1627D, 산출 균주를 영양 배지에서 배양하는 육즙으로부터 WS-1627A, WS-1627B, WS-1627C 및 WS-1627D를 회수하는 단계로 구성되는 WS-1627A, WS-1627B, WS-1627C 및 WS-1627D 및 그 염을 제조하는 방법.
  4. 유효성분으로서, WS-1627A, WS-1627B, WS-1627C 및 WS-1627D에서 선택된 하나 또는 그 이상의 화합물 또는 그 염으로 구성되는 것을 특징으로 하는 동물성장 촉진조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR870001938A 1986-03-04 1987-03-03 돼지 이질의 예방 및 치료제 KR870008910A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868605245A GB8605245D0 (en) 1986-03-04 1986-03-04 Prophylactic & therapeutic agent
GB8605245 1986-03-04

Publications (1)

Publication Number Publication Date
KR870008910A true KR870008910A (ko) 1987-10-22

Family

ID=10593979

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870001938A KR870008910A (ko) 1986-03-04 1987-03-03 돼지 이질의 예방 및 치료제

Country Status (7)

Country Link
US (1) US4906618A (ko)
EP (1) EP0236110B1 (ko)
JP (1) JPS63215687A (ko)
KR (1) KR870008910A (ko)
AT (1) ATE89482T1 (ko)
DE (1) DE3785868T2 (ko)
GB (1) GB8605245D0 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1075483T3 (da) 1998-05-04 2004-03-15 Pfizer Prod Inc Hygromycin A-derivater
EP1369490B1 (en) * 1998-05-04 2006-02-08 Pfizer Products Inc. Method of preparing a composition containing hygromycin A and epi-hygromycin
US20080299098A1 (en) * 2007-04-24 2008-12-04 Chea-Yun Se Broad-Spectrum Antibacterial and Antifungal Activity of Lactobacillus Johnsonii D115
JP2016069333A (ja) * 2014-09-30 2016-05-09 公益財団法人微生物化学研究会 新規化合物、その製造方法、及びその用途、並びに、新規微生物
CA3110075A1 (en) * 2018-08-20 2020-02-27 Northeastern University Hygromycin a compounds and methods of treating spirochete diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5699495A (en) * 1979-12-20 1981-08-10 Kaken Pharmaceut Co Ltd Novel antibiotic substance, its preparation, and pharmaceutical containing said substance as effective component
DE3674513D1 (de) * 1985-06-27 1990-10-31 Takeda Chemical Industries Ltd Verwendung von hygromycin und epihygromycin zur behandlung von dysentrie bei schweinen.
JPS62234021A (ja) * 1986-04-03 1987-10-14 Kitasato Inst:The ブタ赤痢治療剤および予防剤ならびにそれらを用いたブタ赤痢の予防および治療法

Also Published As

Publication number Publication date
JPS63215687A (ja) 1988-09-08
EP0236110A2 (en) 1987-09-09
EP0236110B1 (en) 1993-05-19
ATE89482T1 (de) 1993-06-15
DE3785868T2 (de) 1993-08-26
GB8605245D0 (en) 1986-04-09
DE3785868D1 (de) 1993-06-24
EP0236110A3 (en) 1990-08-29
US4906618A (en) 1990-03-06

Similar Documents

Publication Publication Date Title
GR3034872T3 (en) Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use
EA199901014A1 (ru) C-4"-замещенные макролидные производные
BG104644A (en) Novel macrolides
NO952824D0 (no) Sterile gelsammensetninger for sårbehandling
ZA831451B (en) Process for the preparation of polysaccharide-protein complexes from bacterial capsules,obtained products and immunogenic compositions containing them
AU561016B2 (en) N-glycosylated carboxamide derivatives
PT77898A (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
EA200100416A1 (ru) 13-членные азалиды и их применение в качестве антибиотических агентов
ATE67662T1 (de) Topische antibiotische zusammensetzung zur behandlung der schleimhaeute.
KR870008910A (ko) 돼지 이질의 예방 및 치료제
DE2964602D1 (en) 4,6-di-0-(aminoglycosyl)-1,3-diaminocyclitols, process for their preparation and pharmaceutical compositions containing them
DE3060897D1 (en) Sisomicin derivatives, process for their preparation and their use as medicines
KR910021361A (ko) 항궤양 물질
DZ1407A1 (fr) Dérivés d-substitués des n,n'-ditriméthoxybenzoylepipérazine ainsi que leur procédé de préparation.
AU567018B2 (en) Prazosin-pirbuterol combination for bronchoduation
KR880003628A (ko) 처리된 리피드 조절제
KR890009901A (ko) 3-히드록시-2-(4-메톡시페닐)-5-(2-메틸아미노에틸)-2,3-디히드로-5h-1,5- 벤조티아제핀-4-온 유도체, 그의 제조 및 치료에의 이용
ATE141612T1 (de) Conalbumin und seine derivate enthaltende eisenkomplexe
ZA903111B (en) 2-hydroxy-3-phenoxypropylamino compounds and pharmaceutical compositions containing them
EA200101178A1 (ru) Соль дифосфатпроизводного 4"-замещенного 9-дезокси-9а-аза-9а-гомоэритромицина и ее фармацевтическая композиция
ATE4988T1 (de) Antibiotika, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
FR2421181A1 (fr) Derives de substitution de spirooxazolidinone steroidienne, leur procede de preparation et compositions pharmaceutiques les contenant
ES442505A1 (es) Procedimiento de preparacion de la 4-0-n2',6'-diamino-2',3',6' - tridesoxi-alfa, d-ribohexopiranosiln6-0 - n3" - metila-mino-3",4",6"tridesoxi alfa,d-xilohexopiranosiln2-desoxies- treptamina.
SE7906080L (sv) Farmaceutisk komposition innehallande trimetoprim och n-etyl-sigma-pyridon-3-karboxylsyraderivat
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application
WITB Written withdrawal of application